Vaccinex Inc (VCNX): ????

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Vaccinex Inc (VCNX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	17
Boards Moderated	0
Alias Born	01/10/2021

Re: None

Thursday, 03/10/2022 6:19:14 PM

Thursday, March 10, 2022 6:19:14 PM

????

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent VCNX News

Vaccinex Reports 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:19:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 03:10:30 PM
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology • GlobeNewswire Inc. • 02/21/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 01:06:03 PM
Vaccinex, Inc. Announces Reverse Stock Split • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:34 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:15:59 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:22:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:34:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:32:53 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 09:08:11 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/08/2024 01:20:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 08:43:55 PM
Vaccinex Announces Pricing of $3.7 Million PIPE Financing • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/22/2024 05:15:30 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 09:40:09 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/10/2024 10:16:22 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/08/2024 09:16:04 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:31:17 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/28/2023 09:15:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 09:31:18 PM
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule • GlobeNewswire Inc. • 12/04/2023 01:00:00 PM
Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM

More VCNX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow